S&P 500   4,304.03 (+0.16%)
DOW   34,151.95 (+0.71%)
QQQ   333.52 (+0.14%)
AAPL   173.17 (-0.01%)
MSFT   293.42 (-0.02%)
META   180.33 (-0.31%)
GOOGL   122.00 (-0.07%)
AMZN   145.90 (+1.90%)
TSLA   926.94 (-0.11%)
NVDA   190.29 (-0.02%)
NIO   21.00 (-1.41%)
BABA   93.20 (-1.06%)
AMD   100.73 (-0.28%)
MU   64.33 (-0.57%)
T   18.65 (+1.41%)
CGC   3.85 (+0.79%)
F   16.58 (+1.59%)
GE   81.14 (+1.67%)
DIS   126.45 (+1.76%)
AMC   25.34 (+4.67%)
PYPL   102.73 (+1.20%)
PFE   50.03 (+0.56%)
NFLX   248.38 (-0.29%)
S&P 500   4,304.03 (+0.16%)
DOW   34,151.95 (+0.71%)
QQQ   333.52 (+0.14%)
AAPL   173.17 (-0.01%)
MSFT   293.42 (-0.02%)
META   180.33 (-0.31%)
GOOGL   122.00 (-0.07%)
AMZN   145.90 (+1.90%)
TSLA   926.94 (-0.11%)
NVDA   190.29 (-0.02%)
NIO   21.00 (-1.41%)
BABA   93.20 (-1.06%)
AMD   100.73 (-0.28%)
MU   64.33 (-0.57%)
T   18.65 (+1.41%)
CGC   3.85 (+0.79%)
F   16.58 (+1.59%)
GE   81.14 (+1.67%)
DIS   126.45 (+1.76%)
AMC   25.34 (+4.67%)
PYPL   102.73 (+1.20%)
PFE   50.03 (+0.56%)
NFLX   248.38 (-0.29%)
S&P 500   4,304.03 (+0.16%)
DOW   34,151.95 (+0.71%)
QQQ   333.52 (+0.14%)
AAPL   173.17 (-0.01%)
MSFT   293.42 (-0.02%)
META   180.33 (-0.31%)
GOOGL   122.00 (-0.07%)
AMZN   145.90 (+1.90%)
TSLA   926.94 (-0.11%)
NVDA   190.29 (-0.02%)
NIO   21.00 (-1.41%)
BABA   93.20 (-1.06%)
AMD   100.73 (-0.28%)
MU   64.33 (-0.57%)
T   18.65 (+1.41%)
CGC   3.85 (+0.79%)
F   16.58 (+1.59%)
GE   81.14 (+1.67%)
DIS   126.45 (+1.76%)
AMC   25.34 (+4.67%)
PYPL   102.73 (+1.20%)
PFE   50.03 (+0.56%)
NFLX   248.38 (-0.29%)
S&P 500   4,304.03 (+0.16%)
DOW   34,151.95 (+0.71%)
QQQ   333.52 (+0.14%)
AAPL   173.17 (-0.01%)
MSFT   293.42 (-0.02%)
META   180.33 (-0.31%)
GOOGL   122.00 (-0.07%)
AMZN   145.90 (+1.90%)
TSLA   926.94 (-0.11%)
NVDA   190.29 (-0.02%)
NIO   21.00 (-1.41%)
BABA   93.20 (-1.06%)
AMD   100.73 (-0.28%)
MU   64.33 (-0.57%)
T   18.65 (+1.41%)
CGC   3.85 (+0.79%)
F   16.58 (+1.59%)
GE   81.14 (+1.67%)
DIS   126.45 (+1.76%)
AMC   25.34 (+4.67%)
PYPL   102.73 (+1.20%)
PFE   50.03 (+0.56%)
NFLX   248.38 (-0.29%)
NASDAQ:GHSI

Guardion Health Sciences - GHSI Stock Forecast, Price & News

$0.17
0.00 (-1.11%)
(As of 08/16/2022 02:25 PM ET)
Add
Compare
Today's Range
$0.17
$0.17
50-Day Range
$0.14
$0.17
52-Week Range
$0.13
$1.98
Volume
46,432 shs
Average Volume
2.14 million shs
Market Capitalization
$10.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.68

Guardion Health Sciences MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
298.2% Upside
$0.68 Price Target
Short Interest
Healthy
11.14% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.78mentions of Guardion Health Sciences in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Medical Sector

669th out of 1,124 stocks

Pharmaceutical Preparations Industry

335th out of 555 stocks

GHSI stock logo

About Guardion Health Sciences (NASDAQ:GHSI) Stock

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.

Guardion Health Sciences Price Performance

Shares of NASDAQ:GHSI opened at $0.17 on Tuesday. The company has a 50-day simple moving average of $0.15 and a 200-day simple moving average of $0.22. Guardion Health Sciences has a one year low of $0.13 and a one year high of $1.98.

Wall Street Analysts Forecast Growth

GHSI has been the subject of a number of research reports. Maxim Group reissued a "buy" rating and issued a $0.60 price target on shares of Guardion Health Sciences in a research report on Friday, May 13th. Ascendiant Capital Markets assumed coverage on shares of Guardion Health Sciences in a report on Monday, July 18th. They issued a "buy" rating and a $0.75 target price for the company.

Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

GHSI Stock News Headlines

Guardion Health Sciences Issues Letter to Shareholders
See More Headlines
Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

GHSI Company Calendar

Last Earnings
8/12/2019
Today
8/16/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GHSI
Employees
12
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$0.68
High Stock Price Forecast
$0.75
Low Stock Price Forecast
$0.60
Forecasted Upside/Downside
+298.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-24,750,000.00
Net Margins
-191.10%
Pretax Margin
-191.09%

Debt

Sales & Book Value

Annual Sales
$7.23 million
Cash Flow
$0.09 per share
Book Value
$0.91 per share

Miscellaneous

Free Float
60,529,000
Market Cap
$10.42 million
Optionable
Not Optionable
Beta
0.79














GHSI Stock - Frequently Asked Questions

Should I buy or sell Guardion Health Sciences stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GHSI shares.
View GHSI analyst ratings
or view top-rated stocks.

What is Guardion Health Sciences' stock price forecast for 2022?

2 equities research analysts have issued 12-month price objectives for Guardion Health Sciences' shares. Their GHSI share price forecasts range from $0.60 to $0.75. On average, they expect the company's stock price to reach $0.68 in the next twelve months. This suggests a possible upside of 294.4% from the stock's current price.
View analysts price targets for GHSI
or view top-rated stocks among Wall Street analysts.

How have GHSI shares performed in 2022?

Guardion Health Sciences' stock was trading at $0.6471 on January 1st, 2022. Since then, GHSI stock has decreased by 73.6% and is now trading at $0.1711.
View the best growth stocks for 2022 here
.

When is Guardion Health Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our GHSI earnings forecast
.

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) posted its quarterly earnings results on Monday, August, 12th. The company reported ($0.84) earnings per share (EPS) for the quarter. The business had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative net margin of 191.10% and a negative trailing twelve-month return on equity of 34.25%.

When did Guardion Health Sciences' stock split?

Shares of Guardion Health Sciences reverse split on Monday, March 1st 2021. The 1-6 reverse split was announced on Friday, February 26th 2021. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 26th 2021. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL).

When did Guardion Health Sciences IPO?

(GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at a price of $4.00 per share. WallachBeth Capital and Westpark Capital served as the underwriters for the IPO.

What is Guardion Health Sciences' stock symbol?

Guardion Health Sciences trades on the NASDAQ under the ticker symbol "GHSI."

Who are Guardion Health Sciences' major shareholders?

Guardion Health Sciences' stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (2.56%) and Millennium Management LLC (0.60%).
View institutional ownership trends
.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Guardion Health Sciences' stock price today?

One share of GHSI stock can currently be purchased for approximately $0.17.

How much money does Guardion Health Sciences make?

Guardion Health Sciences (NASDAQ:GHSI) has a market capitalization of $10.54 million and generates $7.23 million in revenue each year. The company earns $-24,750,000.00 in net income (profit) each year or ($0.82) on an earnings per share basis.

How can I contact Guardion Health Sciences?

Guardion Health Sciences' mailing address is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The official website for the company is www.guardionhealth.com. The company can be reached via phone at (800) 873-5141, via email at matthew@plrinvest.com, or via fax at 858-630-5543.

This page (NASDAQ:GHSI) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.